C - Chemistry – Metallurgy – 07 – H
Patent
C - Chemistry, Metallurgy
07
H
C07H 19/20 (2006.01) A61K 31/7064 (2006.01) A61K 31/7076 (2006.01) C07H 19/10 (2006.01)
Patent
CA 2618335
The invention provides novel nucleoside compounds of formula I wherein R1, R2a, R2b, R3, R4, R5, R6, R8a, R9 and R10 are as defined herein which are useful for the treatment of Hepatitis C Virus (HCV) mediated diseases. The invention further provides methods for treatment or prophylaxis of HCV mediated diseases with compounds of formula I and pharmaceutical compositions comprising these compounds.
L'invention concerne des nouveaux composés nucléosides de formule (I) dans laquelle R1, R2a, R2b, R3, R4, R5, R6, R8a, R9 et R10 ont la signification indiquée dans la description, qui sont utilisés pour le traitement de maladies à médiation assurée par le virus de l'hépatite C (VHC). L'invention concerne en outre des méthodes de traitement ou de prophylaxie de maladies à médiation assurée par le VHC à l'aide des composés de formule (I) et des compositions pharmaceutiques comprenant lesdits composés.
Klumpp Klaus
Martin Joseph Armstrong
Mcguigan Christopher
Smith David Bernard
F.hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Antiviral phosphoramidates of 4 ' -substituted pronucleotides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antiviral phosphoramidates of 4 ' -substituted pronucleotides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral phosphoramidates of 4 ' -substituted pronucleotides will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1476164